DK3043810T3 - Immunsystemsmodulatorer - Google Patents

Immunsystemsmodulatorer Download PDF

Info

Publication number
DK3043810T3
DK3043810T3 DK14771713.6T DK14771713T DK3043810T3 DK 3043810 T3 DK3043810 T3 DK 3043810T3 DK 14771713 T DK14771713 T DK 14771713T DK 3043810 T3 DK3043810 T3 DK 3043810T3
Authority
DK
Denmark
Prior art keywords
immune system
system modulators
modulators
immune
Prior art date
Application number
DK14771713.6T
Other languages
English (en)
Inventor
Leif Hakansson
Original Assignee
Canimguide Therapeutics Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Canimguide Therapeutics Ab filed Critical Canimguide Therapeutics Ab
Application granted granted Critical
Publication of DK3043810T3 publication Critical patent/DK3043810T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK14771713.6T 2013-09-09 2014-09-08 Immunsystemsmodulatorer DK3043810T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361875598P 2013-09-09 2013-09-09
PCT/US2014/054612 WO2015035332A1 (en) 2013-09-09 2014-09-08 Immune system modulators

Publications (1)

Publication Number Publication Date
DK3043810T3 true DK3043810T3 (da) 2020-01-27

Family

ID=51585229

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14771713.6T DK3043810T3 (da) 2013-09-09 2014-09-08 Immunsystemsmodulatorer

Country Status (10)

Country Link
US (3) US9657059B2 (da)
EP (2) EP3656391A1 (da)
JP (2) JP6886816B2 (da)
KR (1) KR102162323B1 (da)
CN (2) CN111732652A (da)
AU (1) AU2014317884B2 (da)
CA (1) CA2923160A1 (da)
DK (1) DK3043810T3 (da)
ES (1) ES2777939T3 (da)
WO (1) WO2015035332A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136736A2 (en) 2007-05-08 2008-11-13 Canimguide Therapeutics Ab Immunoregulatory structures from normally occurring proteins
CN111732652A (zh) 2013-09-09 2020-10-02 卡尼姆盖德治疗学公司 免疫系统调节器
WO2016144650A1 (en) * 2015-03-06 2016-09-15 Canimguide Therapeutics Ab Immune system modulators and compositions
US9793852B2 (en) 2015-07-15 2017-10-17 Solarcity Corporation Clamp and bowl mounting system for photovoltaic modules
KR101896777B1 (ko) 2016-10-06 2018-09-07 현대자동차주식회사 내습성이 향상된 배리어 필름의 제조방법 및 이에 의해 제조된 배리어 필름
US20210401926A1 (en) 2018-09-28 2021-12-30 Canimguide Therapeutics Ab Pharmaceutical formulations of peptide inhibitors
CA3127453A1 (en) 2019-01-28 2020-08-06 Mitochondria Emotion, Inc. Trans-4-hydroxycyclohexyl phenyl amide mitofusin activators and methods of use thereof
CA3127590A1 (en) 2019-01-28 2020-08-06 Mitochondria Emotion, Inc. Mitofusin activators and methods of use thereof
CN111649776A (zh) * 2020-04-14 2020-09-11 东莞市创宏医疗科技有限公司 一种无屏检测系统
GB202211043D0 (en) * 2022-07-28 2022-09-14 Univ Birmingham Peptide agonist

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US715368A (en) 1902-05-29 1902-12-09 Isaac N Graham Cutter-bar for harvesters or mowers.
US4215051A (en) 1979-08-29 1980-07-29 Standard Oil Company (Indiana) Formation, purification and recovery of phthalic anhydride
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
WO1993016177A1 (en) 1992-02-11 1993-08-19 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
IT1263831B (it) 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
SE502408C2 (sv) 1993-09-30 1995-10-16 Dataliner Ab Skalmönster vid lägesbestämning med hjälp av en snäv mätstråle
US5888767A (en) 1996-11-27 1999-03-30 The Johns Hopkins University School Of Medicine Method of using a conditionally replicating viral vector to express a gene
TR200002605T2 (tr) 1998-03-11 2000-12-21 G. D. Searle & Co. Nitrik oksit sentaz inhibitörleri olarak faydalı halojene amidino amino asit türevleri
AUPP616498A0 (en) 1998-09-25 1998-10-15 University Of Queensland, The Synthesis of cyclic peptides
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US6703491B1 (en) * 1999-03-17 2004-03-09 Exelixis, Inc. Drosophila sequences
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
AU2001228212A1 (en) 2000-01-18 2001-07-31 Mcgill University Beta-turn peptidomimetic cyclic compounds
US6495674B1 (en) 2000-02-25 2002-12-17 The Salk Institute For Biological Studies Evectins and their use
US7252952B2 (en) 2000-03-06 2007-08-07 Rigel Pharmaceuticals, Inc. In vivo production of cyclic peptides for inhibiting protein—protein interaction
US6417237B1 (en) 2000-06-08 2002-07-09 The Board Of Trustees Of The University Of Illinois Macromolecular drug complexes and compositions containing the same
US7320790B2 (en) * 2001-04-30 2008-01-22 Eli Lilly And Company Humanized antibodies
KR100566911B1 (ko) 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US7084257B2 (en) * 2001-10-05 2006-08-01 Amgen Inc. Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
PT1461359E (pt) * 2002-01-18 2007-06-29 Pf Medicament Anticorpos anti-igf-ir e suas aplicações
US7153685B2 (en) 2002-03-11 2006-12-26 The Board Of Trustees Of The University Of Illinois Tamoxifen and 4-hydroxytamoxifen-activated system for regulated production of proteins in eukaryotic cells
EP1507548B1 (en) * 2002-05-27 2014-10-01 CanImGuide Therapeutics AB Method for determining immune system affecting compounds
CA2488441C (en) 2002-06-03 2015-01-27 Genentech, Inc. Synthetic antibody phage libraries
US7538195B2 (en) * 2002-06-14 2009-05-26 Immunogen Inc. Anti-IGF-I receptor antibody
EP1539234A4 (en) * 2002-09-05 2006-02-15 Medimmune Inc METHODS OF PREVENTING OR TREATING CELLULAR MALIGNITES BY ADMINISTERING CD2 ANTAGONISTS
US20090183270A1 (en) * 2002-10-02 2009-07-16 Adams Thomas R Transgenic plants with enhanced agronomic traits
WO2004064731A2 (en) 2003-01-14 2004-08-05 University Of Washington Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymlplhoid tissues
WO2004081186A2 (en) 2003-03-10 2004-09-23 Applera Corporation Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof
WO2004087947A1 (en) 2003-03-31 2004-10-14 Mcmaster University Aptamer selection method
AU2003902875A0 (en) * 2003-06-10 2003-06-26 The University Of Melbourne Immunomodulating compositions, uses therefor and processes for their production
KR20140033239A (ko) 2003-06-27 2014-03-17 암젠 프레몬트 인코포레이티드 상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그 용도
KR100725315B1 (ko) 2003-11-13 2007-06-07 한미약품 주식회사 면역글로불린 단편을 이용한 단백질 결합체 및 그의제조방법
BRPI0510883B8 (pt) 2004-06-01 2021-05-25 Genentech Inc composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação
KR101131727B1 (ko) 2004-06-11 2012-03-28 가톨릭대학교 산학협력단 ＣＥＡ-특이적인 세포독성 Ｔ세포를 생성하는 재조합 아데노바이러스 ＡｄＶＣＥＡ로 트랜스덕션된 수지상세포, 이를 포함하는 백신 및 약제학적 조성물
FR2873699B1 (fr) 2004-07-29 2009-08-21 Pierre Fabre Medicament Sa Nouveaux anticorps anti igf ir rt leurs utilisations
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
WO2006110091A1 (en) 2005-04-15 2006-10-19 Therim Diagnostica Ab Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
WO2007056448A2 (en) 2005-11-08 2007-05-18 Ambrx, Inc. Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
ES2529065T3 (es) 2005-12-14 2015-02-16 Ambrx, Inc. Composiciones que contienen, procedimientos que implican y usos de aminoácidos no naturales y polipéptidos
AU2006343459A1 (en) * 2005-12-16 2007-11-22 Genentech, Inc. Anti-OX40L antibodies and methods using same
US7816324B2 (en) 2007-03-13 2010-10-19 Board Of Regents, The University Of Texas System Composition and method for the treatment of diseases affected by a peptide receptor
WO2008136736A2 (en) 2007-05-08 2008-11-13 Canimguide Therapeutics Ab Immunoregulatory structures from normally occurring proteins
WO2009047360A1 (en) 2007-10-11 2009-04-16 Novo Nordisk A/S Il-21 antibodies
RU2360924C1 (ru) * 2007-12-21 2009-07-10 Институт биохимии им. А.А. Баха РАН Маркер рака предстательной железы
EP4012714A1 (en) * 2010-03-23 2022-06-15 Iogenetics, LLC. Bioinformatic processes for determination of peptide binding
US8455624B2 (en) * 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
CN111732652A (zh) 2013-09-09 2020-10-02 卡尼姆盖德治疗学公司 免疫系统调节器
WO2016144650A1 (en) 2015-03-06 2016-09-15 Canimguide Therapeutics Ab Immune system modulators and compositions

Also Published As

Publication number Publication date
KR102162323B1 (ko) 2020-10-06
CN105744944A (zh) 2016-07-06
US10301356B2 (en) 2019-05-28
WO2015035332A1 (en) 2015-03-12
CN111732652A (zh) 2020-10-02
JP6886816B2 (ja) 2021-06-16
US20160311854A1 (en) 2016-10-27
EP3043810A1 (en) 2016-07-20
KR20160054531A (ko) 2016-05-16
CN105744944B (zh) 2020-07-07
EP3656391A1 (en) 2020-05-27
ES2777939T3 (es) 2020-08-06
AU2014317884B2 (en) 2017-09-07
CA2923160A1 (en) 2015-03-12
US20190375789A1 (en) 2019-12-12
JP2020019803A (ja) 2020-02-06
US20170298096A1 (en) 2017-10-19
EP3043810B1 (en) 2019-10-23
JP2016531583A (ja) 2016-10-13
US9657059B2 (en) 2017-05-23

Similar Documents

Publication Publication Date Title
DK3848027T3 (da) Octahydro-kondenserede azadecalinglucocorticoidreceptormodulatorer
FI20135538A (fi) Hissijärjestelmä
DK3004155T3 (da) Peptidforbindelse
FI20136147A (fi) Hissijärjestelmä
DK3043810T3 (da) Immunsystemsmodulatorer
DK3007564T3 (da) Struktureret fedtsystem
DK3017139T3 (da) Undersøisk interventionssystem
DE112014004622A5 (de) Mikroreaktorsystem
DE112014004683A5 (de) Ausfallsicheres Kamerasystem
FI10285U1 (fi) Pysäköintijärjestelmä
DE112014004954T8 (de) Abgabesystem
DK2826742T3 (da) Elevator system
DK3074978T3 (da) Interaktivt mediesystem
DE112014004938T8 (de) Abgabesystem
DK3025407T3 (da) Actuator system
DK3017533T3 (da) Aktuatorsystem
DE112014002718T8 (de) Führungssystem
DK2784331T3 (da) Hydraulisk system
DK3027068T3 (da) Pressesystem
DK2839952T3 (da) Forbedret kompositsystem
GB2517013B (en) Facing system
DE112014001214A5 (de) Abgasanlage
DE112014003435A5 (de) Hydrauliksystem
GB2514562B (en) Signage System
EP2960784A4 (en) VIRTUALIZATION SYSTEM